Impact of mismatch repair or microsatellite status on the prognosis and efficacy to chemotherapy in metastatic colorectal cancer patients: A bi-institutional, propensity score-matched study
Identification of two intrinsic epithelial subtypes of colorectal cancer | Nature Genetics
Distribution of MSI-L/MSS colorectal cancers according to the number of... | Download Scientific Diagram
Microsatellite instability: a review of what the oncologist should know | Cancer Cell International | Full Text
A) The expression levels of MSI-high, MSI-low and MSS in colorectal... | Download Scientific Diagram
MSI-H Biomarker | Colorectal Cancer Alliance
Frontiers | Neoadjuvant Immunotherapy for MSI-H/dMMR Locally Advanced Colorectal Cancer: New Strategies and Unveiled Opportunities
Impact of microsatellite status on chemotherapy for colorectal cancer patients with KRAS or BRAF mutation
IJMS | Free Full-Text | The Immunogenicity of Colorectal Cancer in Relation to Tumor Development and Treatment
Molecular and prognostic heterogeneity of microsatellite-unstable colorectal cancer
Microsatellite Stability - MSS Biomarker | Colorectal Cancer Alliance
A predictive biomarker of response to therapy in patients with microsatellite stable metastatic colorectal cancer
Regorafenib plus nivolumab in patients with mismatch repair-proficient/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 study - eClinicalMedicine
Cancers | Free Full-Text | Microsatellite Instability: Diagnosis, Heterogeneity, Discordance, and Clinical Impact in Colorectal Cancer
Stomach and colorectal cancer: AI identifyies patients for immunotherapy • healthcare-in-europe.com
Optimizing Immunotherapy Combinations in Mismatch Repair–Proficient/Microsatellite-Stable Metastatic Colorectal Cancer
A subset of patients with MSS/MSI‑low‑colorectal cancer showed increased CD8(+) TILs together with up‑regulated IFN‑γ
The Impact of Microsatellite Instability Status and Sidedness of the Primary Tumor on the Effect of Cetuximab-Containing Chemotherapy in Patients with Metastatic Colorectal Cancer
Should mismatch repair status be determined in all stage II and III colon cancer patients? | Colorectal Cancer
Microsatellite instable vs stable colon carcinomas: analysis of tumour heterogeneity, inflammation and angiogenesis | British Journal of Cancer
The clinical implications of immunogenomics in colorectal cancer: A path for precision medicine - Riley - 2018 - Cancer - Wiley Online Library
CCIs in colon cancer with MSS and MSI. The directions and number of... | Download Scientific Diagram
Immunotherapy in colorectal cancer: current achievements and future perspective
